findmyKOL
Clinical trialNCT03990896RecruitingPhase 2Interventional

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

SponsorMassachusetts General HospitalEnrollment30Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucsf Medical Center-Mission Bay/benioff Children'S Hospital

    San Francisco, California, United States

    Hope Rugo, MD
    Recruiting
  • Emory University Winship Cancer Institute

    Atlanta, Georgia, United States

    Manali Bhave, MD
    Recruiting
  • Northwestern University

    Chicago, Illinois, United States

    Lisa Flaum, MD
    Recruiting
  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, United States

    Neelima Vidula, MD
    Recruiting
  • Weill Cornell Medicine

    New York, New York, United States

    Massimo Cristofanilli, MD
    Recruiting
  • Vanderbilt University

    Nashville, Tennessee, United States

    Recruiting
  • Md Anderson Cancer Center

    Houston, Texas, United States

    Senthil Damodaran, MD, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Talazoparib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Nov 2021
Primary completion
31 Mar 2027
Completion
30 Apr 2028
Last update posted
6 May 2026
Registered enrollment
30
Registry id
NCT03990896
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.